BR112018072177A2 - composição farmacêutica, recipiente, e, métodos para tratar e prevenir congestão nasal, infecções virais do trato respiratório e/ou inflamação da garganta - Google Patents
composição farmacêutica, recipiente, e, métodos para tratar e prevenir congestão nasal, infecções virais do trato respiratório e/ou inflamação da gargantaInfo
- Publication number
- BR112018072177A2 BR112018072177A2 BR112018072177-8A BR112018072177A BR112018072177A2 BR 112018072177 A2 BR112018072177 A2 BR 112018072177A2 BR 112018072177 A BR112018072177 A BR 112018072177A BR 112018072177 A2 BR112018072177 A2 BR 112018072177A2
- Authority
- BR
- Brazil
- Prior art keywords
- respiratory tract
- pharmaceutical composition
- nasal congestion
- pharmaceutically acceptable
- carboxylic acid
- Prior art date
Links
- 206010028735 Nasal congestion Diseases 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 201000007100 Pharyngitis Diseases 0.000 title abstract 3
- 206010062106 Respiratory tract infection viral Diseases 0.000 title abstract 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 5
- 150000003839 salts Chemical class 0.000 abstract 5
- 208000018569 Respiratory Tract disease Diseases 0.000 abstract 1
- 206010068956 Respiratory tract inflammation Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16169882 | 2016-05-17 | ||
| EP16169882.4 | 2016-05-17 | ||
| PCT/EP2017/061832 WO2017198702A1 (en) | 2016-05-17 | 2017-05-17 | Carboxylic acid for treating/preventing nasal congestion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018072177A2 true BR112018072177A2 (pt) | 2019-02-12 |
Family
ID=56014856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018072177-8A BR112018072177A2 (pt) | 2016-05-17 | 2017-05-17 | composição farmacêutica, recipiente, e, métodos para tratar e prevenir congestão nasal, infecções virais do trato respiratório e/ou inflamação da garganta |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200000751A1 (https=) |
| EP (1) | EP3458043A1 (https=) |
| JP (1) | JP6975473B2 (https=) |
| KR (1) | KR102430892B1 (https=) |
| CN (1) | CN109152754A (https=) |
| AU (1) | AU2017266726A1 (https=) |
| BR (1) | BR112018072177A2 (https=) |
| CA (1) | CA3020485A1 (https=) |
| CL (1) | CL2018003270A1 (https=) |
| MX (1) | MX2018013475A (https=) |
| RU (1) | RU2018143564A (https=) |
| SG (2) | SG10202006016QA (https=) |
| WO (1) | WO2017198702A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11206245B2 (en) * | 2009-10-14 | 2021-12-21 | Trice Imaging, Inc. | Systems and devices for encrypting, converting and interacting with medical images |
| US11948678B2 (en) * | 2009-10-14 | 2024-04-02 | Trice Imaging, Inc. | Systems and devices for encrypting, converting and interacting with medical images |
| GB202004690D0 (en) * | 2020-03-31 | 2020-05-13 | Edinburgh Napier Univ | Composition for enhancing immune response of cells |
| US12414928B2 (en) | 2021-05-14 | 2025-09-16 | Rene Dumalaog Javier | Viral inactivation spray and gargling formulation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063363A (en) * | 1997-05-27 | 2000-05-16 | Goodwin; Gary J | Treatment for upper respiratory tract infections with potassium salts |
| PL193131B1 (pl) * | 1997-12-23 | 2007-01-31 | Schering Corp | Kompozycja farmaceutyczna zawierająca kombinację składników aktywnych i jej zastosowanie |
| US8912174B2 (en) * | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| DE10337186A1 (de) * | 2003-08-13 | 2005-03-17 | Merck Patent Gmbh | Wässrige Wirkstoff-Lösung |
| CA2538760A1 (en) * | 2003-09-19 | 2005-03-31 | Otsuka Pharmaceutical Co., Ltd. | Human .beta.-defensin secretion promoter |
| US20070256812A1 (en) * | 2006-04-19 | 2007-11-08 | Wen-Chen Wei | Multidirectional heat dissipating structure |
| US20070286812A1 (en) * | 2006-06-09 | 2007-12-13 | Toutounghi Camille | Nasal formulation |
| ES2748632T3 (es) * | 2012-10-03 | 2020-03-17 | Proponent Biotech Gmbh | Composición farmacéutica que comprende ácido propiónico para uso en el tratamiento de infecciones víricas |
-
2017
- 2017-05-17 CN CN201780029992.2A patent/CN109152754A/zh active Pending
- 2017-05-17 WO PCT/EP2017/061832 patent/WO2017198702A1/en not_active Ceased
- 2017-05-17 EP EP17723139.6A patent/EP3458043A1/en not_active Withdrawn
- 2017-05-17 BR BR112018072177-8A patent/BR112018072177A2/pt not_active IP Right Cessation
- 2017-05-17 SG SG10202006016QA patent/SG10202006016QA/en unknown
- 2017-05-17 RU RU2018143564A patent/RU2018143564A/ru unknown
- 2017-05-17 CA CA3020485A patent/CA3020485A1/en not_active Abandoned
- 2017-05-17 SG SG11201808322PA patent/SG11201808322PA/en unknown
- 2017-05-17 AU AU2017266726A patent/AU2017266726A1/en not_active Abandoned
- 2017-05-17 KR KR1020187033155A patent/KR102430892B1/ko active Active
- 2017-05-17 US US16/097,784 patent/US20200000751A1/en not_active Abandoned
- 2017-05-17 MX MX2018013475A patent/MX2018013475A/es unknown
- 2017-05-17 JP JP2019513481A patent/JP6975473B2/ja active Active
-
2018
- 2018-11-16 CL CL2018003270A patent/CL2018003270A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG10202006016QA (en) | 2020-07-29 |
| CL2018003270A1 (es) | 2019-02-22 |
| KR102430892B1 (ko) | 2022-08-09 |
| US20200000751A1 (en) | 2020-01-02 |
| RU2018143564A3 (https=) | 2020-07-23 |
| CA3020485A1 (en) | 2017-11-23 |
| CN109152754A (zh) | 2019-01-04 |
| SG11201808322PA (en) | 2018-10-30 |
| AU2017266726A1 (en) | 2018-10-11 |
| JP2019516797A (ja) | 2019-06-20 |
| EP3458043A1 (en) | 2019-03-27 |
| WO2017198702A1 (en) | 2017-11-23 |
| KR20190009294A (ko) | 2019-01-28 |
| JP6975473B2 (ja) | 2021-12-01 |
| RU2018143564A (ru) | 2020-06-17 |
| MX2018013475A (es) | 2019-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015018252A2 (pt) | composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit | |
| BR112015029918A2 (pt) | uso de alta dose de pridopidina para tratar a doença de huntington | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
| BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
| BR112019008431A2 (pt) | aplicação de (s)-norcetamina e sal da mesma como fármaco | |
| JP2013155188A5 (https=) | ||
| BR112015003590A8 (pt) | Métodos para tratamento ou prevenção da asma por administração de um antagonista de il-4r | |
| MX2016000364A (es) | Metodos para tratar o prevenir afecciones oftalmologicas. | |
| BR112015029401A8 (pt) | derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas | |
| BR112015009504A2 (pt) | inibidores de rock | |
| WO2015085143A3 (en) | Therapeutic agents for skin diseases and conditions | |
| MX377175B (es) | Solucion para inhalacion de tiotropio, administrada en forma nebulizada y el uso de la misma para tratar enfermedad pulmonar obstructiva crónica (epoc). | |
| EA201891931A1 (ru) | Новые ингибиторы фосфатидилинозитол-3-киназы гамма | |
| MD4369B1 (ro) | Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| BR112018072177A2 (pt) | composição farmacêutica, recipiente, e, métodos para tratar e prevenir congestão nasal, infecções virais do trato respiratório e/ou inflamação da garganta | |
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| CL2016001707A1 (es) | Tratamiento de trastornos congnitivos con (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma (div. sol. 1178-11). | |
| PH12015502274A1 (en) | Lozenge for treating a sore throat, hoarseness, and associated dry cough and for treating inflammatory diseases of the oral cavity and of the pharynx | |
| BR112015029709A2 (pt) | dihidroetorfina para o fornecimento de alívio da dor e anestesia | |
| MX2018005298A (es) | Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa. | |
| BR112017022984A2 (pt) | dispositivo para facilitar o posicionamento de um cateter para administrar um medicamento em um paciente que esteja respirando espontaneamente | |
| BRPI0918593B8 (pt) | composição farmacêutica para uso no tratamento de infecções sexualmente transmitidas | |
| BR112015031835A8 (pt) | agentes terapêuticos, combinação dos referidos agentes e agente terapêutico adicional, uso dos referidos agentes e da referida combinação para fabricação de medicamento para a profilaxia e/ou tratamento de distúrbios do movimento hipercinético |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2723 DE 14/03/2023. |